<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Halloran CM</submitter><funding>Cancer Research UK</funding><funding>National Institute for Health Research (NIHR)</funding><pagination>e198</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9508971</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>3(3)</volume><pubmed_abstract>Whether a Blumgart anastomosis (BA) is superior to Cattell-Warren anastomosis (CWA) in terms of postoperative pancreatic fistula (POPF) following pancreatoduodenectomy.&lt;h4>Importance&lt;/h4>Complications driven by POPF following pancreatic cancer resection may hinder adjuvant therapy, shortening survival. BA may reduce complications compared to CWA, improving the use of adjuvant therapy and prolonging survival.&lt;h4>Methods&lt;/h4>A multicenter double-blind, controlled trial of patients undergoing resection for suspected pancreatic head cancer, randomized during surgery to a BA or CWA, stratified by pancreatic consistency and duct diameter. The primary end point was POPF, and secondary outcome measures were adjuvant therapy use, specified surgical complications, quality of life, and survival from </pubmed_abstract><journal>Annals of surgery open : perspectives of surgical history, education, and clinical approaches</journal><pubmed_title>A Multicenter, Randomized, Double-Blinded, Clinical Trial Comparing Cattell-Warren and Blumgart Anastomoses Following Partial Pancreatoduodenectomy: PANasta Trial.</pubmed_title><pmcid>PMC9508971</pmcid><funding_grant_id>16186</funding_grant_id><funding_grant_id>16791</funding_grant_id><funding_grant_id>17680</funding_grant_id><funding_grant_id>08/29/02</funding_grant_id><funding_grant_id>8968</funding_grant_id><funding_grant_id>11883</funding_grant_id><funding_grant_id>15957</funding_grant_id><funding_grant_id>16812</funding_grant_id><funding_grant_id>A16791</funding_grant_id><pubmed_authors>Psarelli EE</pubmed_authors><pubmed_authors>Jackson R</pubmed_authors><pubmed_authors>Smith A</pubmed_authors><pubmed_authors>Halloran CM</pubmed_authors><pubmed_authors>Pausch TM</pubmed_authors><pubmed_authors>Gomez D</pubmed_authors><pubmed_authors>O'Reilly DA</pubmed_authors><pubmed_authors>Prachalias A</pubmed_authors><pubmed_authors>Reddy S</pubmed_authors><pubmed_authors>Neoptolemos JP</pubmed_authors><pubmed_authors>Davidson B</pubmed_authors><pubmed_authors>Platt K</pubmed_authors><pubmed_authors>Ghaneh P</pubmed_authors></additional><is_claimable>false</is_claimable><name>A Multicenter, Randomized, Double-Blinded, Clinical Trial Comparing Cattell-Warren and Blumgart Anastomoses Following Partial Pancreatoduodenectomy: PANasta Trial.</name><description>Whether a Blumgart anastomosis (BA) is superior to Cattell-Warren anastomosis (CWA) in terms of postoperative pancreatic fistula (POPF) following pancreatoduodenectomy.&lt;h4>Importance&lt;/h4>Complications driven by POPF following pancreatic cancer resection may hinder adjuvant therapy, shortening survival. BA may reduce complications compared to CWA, improving the use of adjuvant therapy and prolonging survival.&lt;h4>Methods&lt;/h4>A multicenter double-blind, controlled trial of patients undergoing resection for suspected pancreatic head cancer, randomized during surgery to a BA or CWA, stratified by pancreatic consistency and duct diameter. The primary end point was POPF, and secondary outcome measures were adjuvant therapy use, specified surgical complications, quality of life, and survival from </description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Sep</publication><modification>2026-05-31T22:55:39.858Z</modification><creation>2024-11-15T00:40:35.275Z</creation></dates><accession>S-EPMC9508971</accession><cross_references><pubmed>36199490</pubmed><doi>10.1097/AS9.0000000000000198</doi></cross_references></HashMap>